Where to buy sermorelin has four honest answers, and they are not four versions of the same purchase. They differ in what you receive, what the seller is permitted to say, what the transaction asks of you, and what happens if it goes wrong. One of those four columns is open here in a way it is not for most compounds this site covers, and that is the part worth reading first.
Key takeaways
- The compounding pharmacy column is real for sermorelin. Sermorelin acetate was a component of an FDA-approved drug product, which is the condition section 503A sets for a bulk substance without a USP monograph.
- Sermorelin is also absent from FDA's Category 2 bulk substances list in every section, while ibutamoren mesylate sits there under both 503A and 503B and ipamorelin acetate, GHRP-2 and GHRP-6 sit there too.
- A research supplier is a shipping business, not a local one. It sells a lyophilised powder under laboratory-use terms and publishes a lot certificate instead of a prescription.
- The four channels differ most in recourse. A pharmacy fill has a prescriber and a licensed dispenser attached; an overseas marketplace has a tracking number and a hope.
- No channel changes the evidence. The approved indications were paediatric growth hormone deficiency and pituitary diagnostics, and PubMed returns zero papers for sermorelin and anti-aging.
The vendor we point lifters to
Sermorelin from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for lot 38-01260229 assays this vial at 11.31 mg against a 10 mg label, and reports purity and quantity only, with no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Lot certificate published, purity and quantity
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified September 6, 2026.
Where to buy sermorelin: the four channels side by side
Put them in one table before arguing about any of them. The columns that matter are what arrives, what the channel asks of you, and what you can do when something is wrong.
| Channel | What you actually get | What it asks of you | Cost shape |
|---|---|---|---|
| Compounding pharmacy | A compounded preparation dispensed against a prescription | A prescriber, a clinical reason, bloodwork, a pharmacy that fills it | Consultation, labs and a per-fill charge; varies by clinic and no figure we can verify |
| Telehealth hormone clinic | The same pharmacy route with the prescriber bundled in | An intake, labs, usually a recurring plan | A monthly programme price, often bundled and often on a subscription |
| Research supplier | A lyophilised powder in a sealed vial, laboratory-use terms | Your own judgement, and reading the certificate | Verified here: $99.99 list, $72.00 site, $36.00 with the code |
| Overseas marketplace | An unlabelled parcel and a customs risk | Tolerance for total loss | Lowest headline, highest variance |
Two of those rows involve a licensed professional. Two do not. That single distinction drives most of the differences in the other columns.
The pharmacy column is genuinely open here
This is the fact that separates sermorelin from nearly every other compound in this category, and it is the one competing pages get wrong in both directions.
Sermorelin was an approved drug. EMD Serono held it as Geref under two applications: NDA 019863, the diagnostic presentation at 0.05 mg per ampoule, with submissions from May 1991, and NDA 020443, the therapeutic presentation at 0.5 mg and 1 mg per vial, originally approved on September 26, 1997. Both are listed as discontinued in Drugs@FDA, and the product record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons. DailyMed returns no current label, because there is no marketed product to carry one.
Under section 503A a compounder may work with a bulk drug substance that is a component of an FDA-approved drug product even where no USP monograph exists. Sermorelin acetate was exactly that. The route did not need a nomination to any list, which is why sermorelin is absent from FDA's Category 2 bulk substances catalogue in every section, active and withdrawn.
The contrast is the useful part. Ibutamoren mesylate carries a Category 2 listing under both 503A and 503B. Ipamorelin acetate is listed under 503B, as are GHRP-2 and GHRP-6. Kisspeptin-10 is listed under 503A. BPC-157, Melanotan II, Selank, Semax, MOTS-c and epitalon were nominated and then withdrawn. Sermorelin appears in none of those places. A lifter who has read that MK-677 and ipamorelin are hard to obtain legitimately has read something true about those compounds and false about this one.
Telehealth clinics: the same route with the friction pre-paid
Telehealth hormone and longevity clinics sell the prescription route as a product. The intake, the lab requisition, the prescriber and the pharmacy relationship arrive as one bundle, usually on a recurring plan.
What you gain is that somebody else has already solved the hardest part, which is finding a prescriber willing to write for this and a pharmacy willing to fill it. What you lose is price transparency and, frequently, the ability to leave. Subscription structures and multi-month minimums are common in this segment, and a monthly figure quoted in an advert rarely includes the labs.
We do not publish a monthly cost for this route, because we do not have one we can verify. Any specific dollar figure you see attached to a clinic sermorelin programme on a page like this one was almost certainly invented to fill the column, and it is worth treating that way.
Research suppliers: a shipping business, not a local one
This is the channel most readers arriving at this query actually end up in, so it is worth describing accurately rather than either defending or condemning.
A research supplier sells a sealed vial of lyophilised powder under laboratory-use terms. It does not provide a prescriber, does not publish dosing, and does not make human-use claims, because a seller that attaches those claims to an unlabelled product has changed what it is selling in regulatory terms. What it can provide is documentation, and that is the only axis on which these sellers can honestly be compared.
The worked example on this site is Ascension's 10 mg presentation and lot 38-01260229, analysed by MZ Biolabs on February 7, 2026 by HPLC-UV-MS: 99.79% purity, four detected peaks, and 11.31 mg measured against a 10 mg label. That certificate reports purity and quantity. It carries no endotoxin test and no sterility test, and for a powder that gets reconstituted that gap is worth knowing about, which is why our listing checklist treats testing scope as the first thing to read rather than the last.
Scope is a property of the lot. It describes what was published for batch 38-01260229 and not what any vendor does in general.
Overseas marketplaces: the column with no recourse
The fourth channel is the one with the lowest headline price and the widest range of outcomes. An international parcel adds customs exposure, adds transit days, and adds heat, and a lyophilised peptide crossing a border in a warm month is a materially different product on arrival than the same vial dispatched domestically.
The deeper problem is recourse. When a domestic order goes wrong there is a business entity, a written policy and a reversible payment rail. When an overseas order goes wrong there is a tracking number that stopped updating. That asymmetry is the whole argument for domestic stock, and it is set out at more length on our US supply page.
What the channel does not change
Whichever column a reader lands in, the same evidence sits underneath it, and on a site read by lifters it deserves saying plainly rather than in a footnote.
Sermorelin is a secretagogue. It binds the GHRH receptor on the anterior pituitary and prompts the pituitary to release the body's own growth hormone. It is not growth hormone, and it is not HGH by another name.
The literature it comes with is not the literature the market implies. PubMed returns 332 papers mentioning sermorelin, three with it in the title, and zero for sermorelin and anti-aging. ClinicalTrials.gov registers no studies naming the compound, so a trial identifier quoted for sermorelin anywhere is fabricated. The two relevant title papers are a 1999 BioDrugs review of use in children with idiopathic growth hormone deficiency (PMID 18031173) and a 2006 paper on adult-onset growth hormone insufficiency (PMID 18046908).
A prescription makes the transaction legitimate. It does not convert paediatric endocrinology data into adult body composition data, and no channel on the table above can do that either.
Frequently asked questions
Can a compounding pharmacy actually fill sermorelin?
The mechanism exists. Sermorelin acetate was a component of an FDA-approved drug product, which is one of the conditions section 503A sets for compounding with a bulk substance that has no USP monograph. Whether a specific pharmacy chooses to fill it is a separate question, and policies differ.
Why is sermorelin treated differently from ipamorelin or MK-677?
Because of the regulatory record rather than any claim about effect. Ibutamoren mesylate carries a Category 2 listing under both 503A and 503B, and ipamorelin acetate, GHRP-2 and GHRP-6 are listed as well. Sermorelin is absent from that list entirely.
Is the research-supplier channel cheaper than a clinic?
The vial is cheaper than a programme, but they are not the same purchase. A clinic price includes a prescriber, labs and a dispensed preparation. A vial price includes a vial. Comparing the two numbers directly compares things that are not comparable.
Does sermorelin have a current FDA label?
No. Both Geref applications are discontinued and DailyMed returns no current label. The FDA record states the product was not discontinued or withdrawn for safety or effectiveness reasons, which is a commercial history rather than a safety action.
Which channel has the best recourse if an order goes wrong?
The pharmacy route, by a distance, because a licensed dispenser and a prescriber are both attached to the transaction. Domestic research suppliers sit second on written terms and reversible payment. Overseas marketplaces sit last, with a tracking number as the only remedy.
This article is for educational purposes only and is not medical advice. Sermorelin was approved as Geref and is now discontinued, with no current US label; material sold by research suppliers is labeled for laboratory use only and not for human consumption. Speak with a qualified healthcare professional before making any decision involving peptides, injections, or off-label compounds.